CXCR4表达上调与HER2介导乳腺癌转移的相关性研究

doi:10.3969/j.issn.1004-616x.2008.04.014

Carcinogenesis, Teratogenesis & Mutagenesis ›› 2008, Vol. 20 ›› Issue (4): 303-307.doi: 10.3969/j.issn.1004-616x.2008.04.014

Previous Articles Next Articles

Upregulation of CXCR4 and HER2_mediated Breast Cancer Metastasis

YANG Qing_ling1, DING Yong_xing2, LI Cheng_hua2,CHEN Chang_jie1, ZHANG Ju1, WANG Hui1

1.Department of Biochemistry ＆ Molecular Biology,Bengbu Medical College, Bengbu 233000,Anhui; 2. Branch of Tumor, The Central Hospital of Bengbu, Bengbu 233000, Anhui,China

Received:2007-09-11 Revised:2007-10-30 Online:2008-07-30 Published:2008-07-30

Abstract

Abstract: BACKGROUND AND AIM: We evaluated the expression of CXCR4 and HER2, the inhibition of Herceptin on CXCR4 expression and the in vitro metastatic action in breast cancer cells. MATERIALS AND METHODS: Biomarker expression levels in paraffin_embedded tissue sections of breast cancer were evaluated using immunohistochemical staining. The protein expression of CXCR4 was studied by Western blot and the mRNA expression was by RT_PCR after treatment with Herceptin . Adhesion and chemotaxis assays were used to evalvate the effect of Herceptin on breast cancer cells with different HER2 expressions. RESULTS: Cytoplasmic CXCR4 was positively correlated with lymph node－positive tumors(P=0.032)and different stage of breast cancer(P=0.000)and the expression of HER2(P=0.015). The protein and mRNA expressions of CXCR4 were decreased after treatment with Herceptin in breast cancer cells with HER2 overexpression(P<0.05)and activity of cell adherence to fibronectin(FN) and migration to SDF_1α were inhibited. CONCLUSION: HER2_mediated homing to metastatic organs and upregulation of CXCR4 may be key factors for HER2_mediated breast cancer metastasis.

Key words: CXCR4, HER2, breast cancer, metastasis

YANG Qing_ling, DING Yong_xing, LI Cheng_hua, CHEN Chang_jie, ZHANG Ju, WANG Hui. Upregulation of CXCR4 and HER2_mediated Breast Cancer Metastasis[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2008, 20(4): 303-307.

[1]	XIN Yumeng, LIANG Huanxi, YU Yuehua, SUN Zhenxiao. Network pharmacology and molecular docking mechanisms of licorice and dried ginger decoction against breast cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 7-13.
[2]	ZHAO Yan, SUN Zhenxiao. Metformin inhibitd proliferation and migration of human breast cancer cell in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 35-39.
[3]	GUO Zhaomeng, ZHANG Hua, ZHANG Peng. Mechanisms of Orai1 on invasion and epithelial-mesenchymal transformation in nasopharyngeal carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 420-425.
[4]	FANG Yutong, ZHANG Qunchen, HONG Chaoqun, CHEN Chunfa, CHEN Jiongyu, ZHANG Rendong, WU Jundong. Mechanisms of miR-221 and miR-222 on expression of GATA3 and FOXA1 and their effects in breast cancer [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 435-441,460.
[5]	ZHANG Shimin, ZHAO Ruijun. Expression of protein tyrosine phosphatase receptor J in breast cancer tissues and its relationship with clinical prognosis [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(4): 276-279,285.
[6]	CHENG Bin, WANG Xinyu, SUN Yu, ZHANG Jiatai, DONG Shuying. Inhibition of metformin on phthalate-induced proliferation and migration of MCF-7 breast cancer cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 197-202.
[7]	LUO Jiao, ZHANG Kunchi, ZHOU Li. Analysis of differentially expressed microRNAs between the triple negative breast cancer cell line MDA-MB-231 and its brain metastasis cell line [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 218-224.
[8]	LI Weiwei, ZHU Ying. Data mining analyses of expression and prognostic values of the MYB family in breast cancer [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 414-422.
[9]	CHEN Mianling, MA Shuoyi. Regulation of migration and invasion of triple-negative breast cancer cell MDA-MB-231 by miR-21 via targeting PDCD4 [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(4): 292-297.
[10]	ZHANG Huijuan, HUANG Dayuan, ZHANG Jie, TANG Haiou, XIE Anxin, TAN Dunyong. Effects of SF1a-PRLR and ΔS2 SF1a-PRLR on proliferation and microRNA expressionin MCF-7 breast cancer cell [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 203-208.
[11]	SUN Quanwu, DU Xiaoping, HAO Jie, SHI Rong, LIU Bo, HUANG Haiyun. β1 integrin expression in breast cancer patients with pathological nipple discharge [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 368-372.
[12]	WANG Lan, ZHANG Yongdong, GUO Hongyun, WANG Tao, WANG Haitao, GUO Huan, YANG Suisheng, LI Xiaoqin, SU Haixiang. Relationships between XRCC3 polymorphisms and breast cancer in northern Chinese women [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(5): 392-396,400.
[13]	DU Juan, HU Xiangyang, LIU Dan, HU Wei, CHEN Tao. Inhibitory effect of total alkaloids of Tougucao on bone metastasis of breast cancer cells in mice [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(6): 435-441.
[14]	XIAO Hongmei, PAN Tianqi, DONG Shunan, FU Lingmeng, WANG Shaokang, SUN Guiju. Menopausal status on risk for breast cancer from tea consumption: a meta-analysis [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(5): 395-399.
[15]	JIANG Pengtao, HU Zhifang, GAO Xingchun, GUO Na, ZHANG Dian, JIANG Fengliang. Involvement of p53 in regulation of DNA damage-induced cell death in MDA-MB-231 [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2018, 30(5): 349-353.

Upregulation of CXCR4 and HER2_mediated Breast Cancer Metastasis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments